PT90249A - Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t - Google Patents

Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t

Info

Publication number
PT90249A
PT90249A PT90249A PT9024989A PT90249A PT 90249 A PT90249 A PT 90249A PT 90249 A PT90249 A PT 90249A PT 9024989 A PT9024989 A PT 9024989A PT 90249 A PT90249 A PT 90249A
Authority
PT
Portugal
Prior art keywords
oxindole
carboxamides
substituted
cell
mammal
Prior art date
Application number
PT90249A
Other languages
English (en)
Other versions
PT90249B (pt
Inventor
Henry James Showell
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT90249A publication Critical patent/PT90249A/pt
Publication of PT90249B publication Critical patent/PT90249B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
PT90249A 1988-04-13 1989-04-11 Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t PT90249B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/181,142 US4853409A (en) 1988-04-13 1988-04-13 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function

Publications (2)

Publication Number Publication Date
PT90249A true PT90249A (pt) 1989-11-10
PT90249B PT90249B (pt) 1994-06-30

Family

ID=22663072

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90249A PT90249B (pt) 1988-04-13 1989-04-11 Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t

Country Status (17)

Country Link
US (1) US4853409A (pt)
EP (1) EP0337628B1 (pt)
JP (1) JPH01311022A (pt)
KR (1) KR920002328B1 (pt)
AT (1) ATE89725T1 (pt)
AU (1) AU601326B2 (pt)
CA (1) CA1324762C (pt)
DE (1) DE68906707T2 (pt)
DK (1) DK174289A (pt)
HU (1) HU204996B (pt)
IE (1) IE62751B1 (pt)
IL (1) IL89872A (pt)
MY (1) MY103872A (pt)
NZ (1) NZ228712A (pt)
PH (1) PH25857A (pt)
PT (1) PT90249B (pt)
ZA (1) ZA892622B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
DK0680321T3 (da) * 1993-01-22 1999-06-14 Pfizer Lysinsalt af 6-chlor-5-fluor-3-(2-thenoyl)-2-oxindol-1-carboxamid
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US5545656A (en) * 1995-04-05 1996-08-13 Pfizer Inc. 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
SK281254B6 (sk) * 1995-07-13 2001-01-18 Smithkline Beecham Corporation Použitie@kán-2-propánamínu, farmaceutický prostriedok s jeho obsahom a jeho použitie
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
WO2006105796A1 (en) * 2005-04-08 2006-10-12 Leo Pharma A/S Novel indolinone derivatives
EP2886541A1 (en) * 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3413572A1 (de) * 1984-04-11 1985-10-24 Hoechst Ag, 6230 Frankfurt Oxindol-verbindungen zur behandlung der epilepsie
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
AU6898287A (en) * 1986-01-30 1987-08-25 University Of Utah, The Treatment of bone loss
US5036099A (en) * 1987-02-02 1991-07-30 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Also Published As

Publication number Publication date
DE68906707D1 (de) 1993-07-01
IL89872A (en) 1994-06-24
MY103872A (en) 1993-09-30
HUT52376A (en) 1990-07-28
IL89872A0 (en) 1989-12-15
ZA892622B (en) 1990-11-28
JPH01311022A (ja) 1989-12-15
EP0337628B1 (en) 1993-05-26
KR890015740A (ko) 1989-11-25
AU3271289A (en) 1989-10-19
AU601326B2 (en) 1990-09-06
KR920002328B1 (ko) 1992-03-21
HU204996B (en) 1992-03-30
PT90249B (pt) 1994-06-30
DE68906707T2 (de) 1993-09-16
ATE89725T1 (de) 1993-06-15
IE62751B1 (en) 1995-02-22
EP0337628A2 (en) 1989-10-18
EP0337628A3 (en) 1991-01-02
US4853409A (en) 1989-08-01
DK174289D0 (da) 1989-04-12
CA1324762C (en) 1993-11-30
PH25857A (en) 1991-12-02
NZ228712A (en) 1997-02-24
IE891171L (en) 1989-10-13
DK174289A (da) 1989-10-16

Similar Documents

Publication Publication Date Title
PT90249A (pt) Metodo para a utilizacao de 2-oxindole-1-carboxamidas 3-substituidas para a supressao da funcao das celulas t
DK1319669T3 (da) Kemisk modificeret vævsinhibitor af type-3-metalloproteinase- (TIMP-3) sammensætning samt fremgangsmåder
SE7903186L (sv) Cerebralverksamt medel
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
FR2677019B1 (fr) Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
GB8604528D0 (en) Therapeutic agents
IT8320435A0 (it) Composizione per il trattamento dell'acne.
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
DK174389A (da) Anvendelse af 3-substituerede 2-oxindol-1-carboxamid-forbindelser til fremstilling af farmaceutiske praeparater til inhibering af interleukin-1-biosyntese
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
IT1215332B (it) Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
FI891473A (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-aryyli-4-piperidiinikarbinolien valmistamiseksi
KR900700136A (ko) 특정 paf 길항제/항히스타민제 조성물
DK52685D0 (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
ATE120447T1 (de) Polyamin-derivate als antineoplastische mittel.
MX12192A (es) Composicion farmaceutica para reducir o impedir las arritmias
IT1145433B (it) Composizione farmaceutiche impiegabili per il trattamento dell'ipertensione
ES2052701T3 (es) Agente hipouricemico que contiene ponalrestat.
IT8619249A0 (it) Kit per la determinazione dell'attivita' proliferativa nei tumori umani.
ES2053808T3 (es) Nuevos compuestos azolicos.
IT8024828A0 (it) Impiego dell'alfa-chetoglutarato di piridossina nella terapia della iperlattacidemia.
IT8847887A0 (it) Trattamento dell'infertilita'
IT8220082A0 (it) Composizione atta al trattamento terapeutico dei tumori.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19931206

MM3A Annulment or lapse

Effective date: 20050606